Brief: Nuformix Submits Draft Application For Orphan Drug Designation For NXP002

Nuformix

13/01/2025 07:40

Jan 13 (Reuters) - Nuformix PLC  NFXN.L :
    * NUFORMIX PLC  - NXP002 ORPHAN DRUG DESIGNATION DRAFT
APPLICATION
    * NUFORMIX PLC - PRE-SUBMISSION MEETING WITH EMA SCHEDULED
FOR END
OF JANUARY 2025

Source text:  ID:nRSM9865Sa 
Further company coverage:  NFXN.L 

 ((Reuters.Briefs@thomsonreuters.com))